LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis

References

• BiermannJSAdkinsDRAgulnikMBone cancerJ Natl Compr Canc Netw201311668872323744868
   PubMed Web of Science ®Google Scholar
• National Institutes of HealthSEER; Cancer Stat Facts: Bone and Joint Cancer Available from: https://seer.cancer.gov/statfacts/html/bones.htmlAccessed November 2, 2017
   Google Scholar
• MialouVPhilipTKalifaCMetastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome – the French pediatric experienceCancer200510451100110916015627
   PubMed Web of Science ®Google Scholar
• MirabelloLTroisiRJSavageSAOsteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results ProgramCancer200911571531154319197972
   PubMed Web of Science ®Google Scholar
• KagerLZoubekAPotschgerUPrimary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocolsJ Clin Oncol200321102011201812743156
   PubMed Web of Science ®Google Scholar
• GorlickRAndersonPAndrulisIBiology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summaryClin Cancer Res20039155442545314654523
   PubMed Web of Science ®Google Scholar
• OmerNLe DeleyMCPiperno-NeumannSPhase-II trials in osteosarcoma recurrences: a systematic review of past experienceEur J Cancer2017759810828219023
   PubMed Web of Science ®Google Scholar
• EbbDMeyersPGrierHPhase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children’s oncology groupJ Clin Oncol201230202545255122665540
   PubMed Web of Science ®Google Scholar
• PappoASVassalGCrowleyJJA phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyCancer2014120162448245624797726
   PubMed Web of Science ®Google Scholar
• ZalupskiMMRankinCRyanJRAdjuvant therapy of osteosarcoma – a phase II trial: Southwest Oncology Group study 9139Cancer2004100481882514770440
   PubMedGoogle Scholar
• MartinJWSquireJAZielenskaMThe genetics of osteosarcomaSarcoma2012201262725422685381
   PubMedGoogle Scholar
• GuttmanMDonagheyJCareyBWlincRNAs act in the circuitry controlling pluripotency and differentiationNature2011477736429530021874018
   PubMed Web of Science ®Google Scholar
• PengWXKoiralaPMoYYLncRNA-mediated regulation of cell signaling in cancerOncogene2017365661566728604750
   PubMed Web of Science ®Google Scholar
• MathieuELBelhocineMDaoLTPuthierDSpicugliaSRôle des longs ARN non codants dans le développement normal et pathologique [Functions of lncRNA in development and diseases]Med Sci (Paris)2014308–9790796 French25174757
   PubMedGoogle Scholar
• ZhaoHHouWTaoJUpregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/beta-catenin signaling pathwayAm J Transl Res2016883503351227648140
   PubMed Web of Science ®Google Scholar
• Yun-BoFXiao-PoLXiao-LiLGuo-LongCPeiZFa-MingTLncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcomaOpen Med (Wars)201611116316728352787
   PubMedGoogle Scholar
• SunXHYangLBGengXLWangRZhangZCIncreased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcomaInt J Clin Exp Pathol2015832994300026045809
   PubMed Web of Science ®Google Scholar
• ZhangCLZhuKPMaXLAntisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2Cancer Lett2017396667528323030
   PubMed Web of Science ®Google Scholar
• ParmarMKTorriVStewartLExtracting summary statistics to perform meta-analyses of the published literature for survival endpointsStat Med19981724281528349921604
   PubMed Web of Science ®Google Scholar
• MaBLiMZhangLUpregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosar-comaTumour Biol20163744445445526499949
   PubMedGoogle Scholar
• WangYYangTZhangZLong non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cellsCancer Sci2017108585986728205334
   PubMed Web of Science ®Google Scholar
• LiWXiePRuanWHOverexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosisJ Bone Oncol201652808527335776
   PubMed Web of Science ®Google Scholar
• WenJJMaYDYangGSWangGMAnalysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcomaEur Rev Med Pharmacol Sci201721349850328239821
   PubMedGoogle Scholar
• ChenFMoJZhangLLong noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcriptionTumour Biol20163710134031341227460090
   PubMedGoogle Scholar
• JuLZhouYMYangGSUp-regulation of long non-coding RNA BCAR4 predicts a poor prognosis in patients with osteosarcoma, and promotes cell invasion and metastasisEur Rev Med Pharmacol Sci201620214445445127874956
   PubMed Web of Science ®Google Scholar
• LiWHeXXueRCombined over-expression of the hypoxia-inducible factor 2alpha gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcomaPathol Res Pract20162121086186627623205
   PubMedGoogle Scholar
• GaoKTLianDLong non-coding RNA MALAT1 is an independent prognostic factor of osteosarcomaEur Rev Med Pharmacol Sci201620173561356527649655
   PubMed Web of Science ®Google Scholar
• LiFCaoLHangDWangFWangQLong non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcomaInt J Clin Exp Pathol201589114141142026617868
   PubMed Web of Science ®Google Scholar
• XiaWKLinQFShenDLiuZLSuJMaoWDClinical implication of long noncoding RNA 91H expression profile in osteosarcoma patientsOnco Targets Ther201694645465227555785
   PubMed Web of Science ®Google Scholar
• ZhouDKYangXWLiHYangYZhuZJWuNUp-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcomaInt J Biol Markers2017321e108e11228009431
   PubMedGoogle Scholar
• TianZZGuoXJZhaoYMFangYDecreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcomaInt J Clin Exp Pathol2015811151381514226823857
   PubMed Web of Science ®Google Scholar
• CongMLiJJingRLiZLong non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcomaTumour Biol20163779441945026781978
   PubMedGoogle Scholar
• UzanVRLengertABoldriniEHigh expression of HULC is associated with poor prognosis in osteosarcoma patientsPLoS One2016116e015677427253450
   PubMed Web of Science ®Google Scholar
• YoungTLMatsudaTCepkoCLThe noncoding RNA taurine upregu-lated gene 1 is required for differentiation of the murine retinaCurr Biol200515650151215797018
   PubMed Web of Science ®Google Scholar
• QinCFZhaoFLLong non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathwayEur Rev Med Pharmacol Sci201721102377238428617552
   PubMed Web of Science ®Google Scholar
• LiTLiuYXiaoHXuGLong non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancerBreast Cancer201724453554327848085
   PubMedGoogle Scholar
• WangFLiXXieXZhaoLChenWUCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasionFEBS Lett2008582131919192718501714
   PubMed Web of Science ®Google Scholar
• ChenPWanDZhengDZhengQWuFZhiQLong non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancerBiomed Pharmacother2016831220122627562722
   PubMed Web of Science ®Google Scholar
• NieWGeHJYangXQLncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3pCancer Lett201637119910626655272
   PubMed Web of Science ®Google Scholar
• MeijerDvan AgthovenTBosmaPTNooterKDorssersLCFunctional screen for genes responsible for tamoxifen resistance in human breast cancer cellsMol Cancer Res20064637938616778085
   PubMedGoogle Scholar
• LiNGaoWJLiuNSLncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transitionEur Rev Med Pharmacol Sci20172192075208628537678
   PubMed Web of Science ®Google Scholar
• PanzittKTschernatschMMGuellyCCharacterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNAGastroenterology2007132133034217241883
   PubMed Web of Science ®Google Scholar
• ZhaoYGuoQChenJHuJWangSSunYRole of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigationOncol Rep201431135836424247585
   PubMed Web of Science ®Google Scholar
• WangYFZhangSLiXQWangYExpression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survivalEur Rev Med Pharmacol Sci201620193987399127775802
   PubMed Web of Science ®Google Scholar